Analyte | Gravimetrically Weighted Value | Units | Stability (Days) |
---|---|---|---|
Buprenorphine | 100 | ng/mL | 25 days |
Norbuprenorphine | 100 | ng/mL | 25 days |
Codeine | 100 | ng/mL | 30 days |
Fentanyl | 10 | ng/mL | 30 days |
Norfentanyl | 10 | ng/mL | 30 days |
Hydrocodone | 100 | ng/mL | 30 days |
Hydromorphone | 100 | ng/mL | 30 days |
Meperidine | 100 | ng/mL | 30 days |
Methadone | 100 | ng/mL | 30 days |
Methadone Primary Metabolite (EDDP) | 100 | ng/mL | 30 days |
Morphine | 100 | ng/mL | 30 days |
Oxycodone | 100 | ng/mL | 30 days |
Oxymorphone | 100 | ng/mL | 30 days |
Tapentadol | 100 | ng/mL | 25 days |
Tramadol | 100 | ng/mL | 25 days |
Product Contains: Buprenorphine, Norbuprenorphine, Codeine, Fentanyl, Norfentanyl, Hydrocodone, Hydromorphone, Meperidine, Methadone, Methadone Primary Metabolite (EDDP), Morphine, Oxycodone, Oxymorphone, Tapentadol, Tramadol
Matrix | Urine |
Unit Size | 5x5mL |
Form | Lyophilized |
Shelf Life | 30 months |
Stability | 25 - 30 days |
Storage | Store dried control material at 2-8°C (35-46°F). |
There are a wide variety of compounds utilized to control pain. These compounds and their metabolites are excreted in urine. At the present time, the healthcare industry has uses urine pain drug screening to confirm compliance and optimize dosage.